Literature DB >> 20362623

Epidemiological study of Brucellosis in cattle, immunized with Brucella abortus RB51 vaccine in endemic zones.

Enrique Herrera-López1, Francisco Suárez-Güemes, Laura Hernández-Andrade, Dionicio Córdova-López, Efrén Díaz-Aparicio.   

Abstract

In this study the behavior of the Brucella abortus RB51 vaccine was evaluated in bovine herds, with different prevalence of Brucellosis. A prospective longitudinal study was made, in two dairies, one of low prevalence (9%) with 538 cows, and the other of high prevalence (15%) with 612 cows. The cattle were vaccinated twice 90 days apart with RB51 at a dose of 1×10(9)cfu/ml. The monthly incidence was determined during 660 days of observation. In the low prevalence dairy, all positive animals were eliminated as soon as they were diagnosed as positive and in this herd the number of new cases decreased to less than 1% between days 120, and day 660. In the dairy with high prevalence, positive cows were not eliminate resulting in the herd increasing its incidence by the end of the first year. Once positive animals were eliminated the incidence diminishes by day 660 to less of 1%. The odds ratio (OR) in the group of cows with abortion history, in the low prevalence dairy, was of 4.5 (1.2; 16.6), in the dairy ranch with high prevalence it presented an OR of 3.6 (1.5; 8.5). The conclusion from this study was that in brucellosis endemic zones, vaccination with RB51 by itself is not enough to control disease. It is mandatory that the initial elimination of all positive cows at the time of vaccination, the continued elimination of all new positive animals be adhered to for long periods of time.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20362623     DOI: 10.1016/j.vaccine.2010.03.057

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Brucella species circulating in rural and periurban dairy cattle farms: a comparative study in an endemic area.

Authors:  Saeed Alamian; Karim Amiry; Akram Bahreinipour; Afshar Etemadi; Majid Tebianian; Mohammad Hossein Fallah Mehrabadi; Maryam Dadar
Journal:  Trop Anim Health Prod       Date:  2021-03-08       Impact factor: 1.559

Review 2.  What have we learned from brucellosis in the mouse model?

Authors:  María-Jesús Grilló; José María Blasco; Jean Pierre Gorvel; Ignacio Moriyón; Edgardo Moreno
Journal:  Vet Res       Date:  2012-04-13       Impact factor: 3.683

Review 3.  Retrospective and prospective perspectives on zoonotic brucellosis.

Authors:  Edgardo Moreno
Journal:  Front Microbiol       Date:  2014-05-13       Impact factor: 5.640

4.  Novel Solutions for Vaccines and Diagnostics To Combat Brucellosis.

Authors:  Satadru Sekhar Mandal; Lucy Duncombe; N Vijaya Ganesh; Susmita Sarkar; Laurence Howells; Philip J Hogarth; David R Bundle; John McGiven
Journal:  ACS Cent Sci       Date:  2017-03-03       Impact factor: 14.553

5.  Brucella abortus S19 GFP-tagged vaccine allows the serological identification of vaccinated cattle.

Authors:  Carlos Chacón-Díaz; Ana Zabalza-Baranguá; Beatriz San Román; José-María Blasco; Maite Iriarte; Dariana Salas-Alfaro; Gabriela Hernández-Mora; Elías Barquero-Calvo; Caterina Guzmán-Verri; Esteban Chaves-Olarte; María-Jesús Grilló; Edgardo Moreno
Journal:  PLoS One       Date:  2021-11-22       Impact factor: 3.240

6.  Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review.

Authors:  Atieh Darbandi; Shabnam Zeighamy Alamdary; Maryam Koupaei; Roya Ghanavati; Mohsen Heidary; Malihe Talebi
Journal:  Front Vet Sci       Date:  2022-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.